Abstract
Plasma beta-endorphin (beta-E) concentration was determined before, during, and after a standardized incremental exercise test to maximal capacity in eight type I diabetic patients and eight normal control subjects. Diabetic patients were studied under normoglycemic and hyperglycemic conditions in a single-blind random fashion to differentiate between the effects of acute hyperglycemia and of diabetes per se on the beta-E response to exercise. The perceived magnitude of leg effort elicited by exercise was evaluated using a category scale. Whereas plasma beta-E concentrations increased in control subjects with increasing workload, causing significantly higher beta-E levels at the end of exercise than at the beginning (P < .001), no such increase could be observed in the diabetic patients under normoglycemic and hyperglycemic conditions. In addition, baseline plasma beta-E concentrations were significantly lower in normoglycemic (P < .01) and hyperglycemic (P < .001) diabetic patients than in control subjects. Even during the recovery period, patients' beta-E levels remained significantly lower than those of control subjects. At submaximal levels of power output, the perceived intensity of leg effort was significantly higher in n...Continue Reading
References
Jan 27, 1977·Nature·J MaddenJ D Barchas
Dec 15, 1977·Nature·J RossierF E Bloom
Jul 29, 1978·British Medical Journal·P DandonaA G Beckett
May 1, 1992·Diabetes·A L McCall
Jun 1, 1992·The American Review of Respiratory Disease·K J KillianE J Campbell
Feb 1, 1990·Diabetes Care·J J RuegemerJ M Miles
Jan 1, 1989·Psychopharmacology·K RamabadranM M Puig
Jan 1, 1988·Journal of Endocrinological Investigation·S B SolerteE Ferrari
Jan 1, 1987·Nephron·S B SolerteE Ferrari
Apr 1, 1988·Journal of the American College of Cardiology·C FalconeC Montemartini
Sep 1, 1988·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·L J FormanP Vasilenko
Jan 1, 1988·Muscle & Nerve·P J Dyck
Sep 3, 1981·The New England Journal of Medicine·D B CarrJ W McArthur
Sep 3, 1981·The New England Journal of Medicine·O Appenzeller
Aug 1, 1982·The Journal of Clinical Endocrinology and Metabolism·R H GernerD H Catlin
Nov 15, 1983·The Biochemical Journal·E H AllanM A Titheradge
Feb 1, 1983·Clinical Endocrinology·C MorettiG M Besser
Feb 1, 1993·Diabetes·T WankeK Irsigler
Citations
Aug 26, 1998·Pharmacology, Biochemistry, and Behavior·R B KanarekK E D'Anci
Jan 1, 1997·Peptides·G A OlsonA J Kastin
Dec 16, 2011·The Journal of Clinical Endocrinology and Metabolism·Sofiya MilmanIlan Gabriely
May 15, 2015·Scandinavian Cardiovascular Journal : SCJ·Thomas BirkelundHanne Berg Ravn
Sep 17, 2009·Pediatric Diabetes·Kenneth RobertsonMichael C Riddell
Oct 3, 2008·Pediatric Diabetes·Jaime S Rosa, Pietro R Galassetti
Jan 24, 2008·Pediatric Diabetes·Kenneth RobertsonRagnar Hanas
Sep 4, 2014·Pediatric Diabetes·Kenneth RobertsonRagnar Hanas
Dec 19, 2014·British Journal of Pharmacology·John P HeadrickJason N Peart
Apr 24, 2012·Diabetes·Sofiya MilmanIlan Gabriely
Aug 18, 2009·Brain Research Bulletin·Patricia J McLaughlinIan S Zagon
Aug 23, 2018·Pediatric Diabetes·Peter AdolfssonSabine E Hofer
Aug 30, 2000·Oncogene·S PanigoneD Delia
Aug 25, 2021·International Immunopharmacology·Hai HuangFengping Shan